<DOC>
	<DOCNO>NCT00437866</DOCNO>
	<brief_summary>Background : Anemia chronic heart failure ( CHF ) directly link increase mortality reduce exercise capacity . The pathomechanism development anemia CHF well understood . Impairment iron homeostasis discuss one major trigger anemia chronic disease . Hepcidin recently describe central regulator iron homeostasis . Main hypothesis : Plasma hepcidin level alter anemic CHF patient compare non anemic control might main contribute factor anemia CHF . Iron regulator-hypothesis High level cytokine CHF patient cause up-regulation hepcidin , turn lead low iron uptake cause anemia . In case venous hepcidin hemoglobin concentration correlate cytokine level . Erythropoietin regulator-hypothesis Dysregulation erythropoietin system result anemia , repress hepcidin . This lead negative correlation hemoglobin hepcidin plasma . Methods : 100 consecutive patient diagnose systolic CHF prospectively include study . Iron status assess hepcidin , erythropoietin well interleukin-1 , interleukin-6 soluble TNF alpha receptor level measure ELISA . Patients follow one year mortality , rehospitalization worsen CHF document .</brief_summary>
	<brief_title>Hepcidin Anemic Chronic Heart Failure ( CHF ) Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hepcidins</mesh_term>
	<criteria>1 . Systolic leave ventricular dysfunction ( LVEF &lt; 45 % ) 2 . Signed informed consent 1 . Women child bear potential 2 . Pregnancy 3 . Non cardiac illness limit life expectancy &lt; 1 year 4 . Renal disease noncardiac reason 5 . Malignancy 6 . Chronic inflammatory disease 7 . Acute infection 8 . Erythropoietin therapy iron substitution within last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>